The activation or repression of a gene's expression is primarily controlled by changes in the proteins that occupy its regulatory elements. The most common method to identify proteins associated with genomic loci is chromatin immunoprecipitation (ChIP). While having greatly advanced our understanding of gene expression regulation, ChIP requires specific, high quality, IP-competent antibodies against nominated proteins, which can limit its utility and scope for discovery. Thus, a method able to discover and identify proteins associated with a particular genomic locus within the native cellular context would be extremely valuable. Here, we present a novel technology combining recent advances in chemical biology, genome targeting, and quantitative mass spectrometry to develop genomic locus proteomics, a method able to identify proteins which occupy a specific genomic locus.
We fused the catalytically dead RNA-guided nuclease Cas9 (dCas9) (12, 13) to the engineered ascorbate peroxidase APEX2 (14) to biotinylate proteins proximal to defined genomic loci for subsequent enrichment and identification by liquid chromatography-mass spectrometry (LC-MS/MS) (Figure 1 A-B) . For this proof-ofprinciple study, dCAS9 was chosen over transcription activator-like effectors (TALEs) or engineered zinc finger nucleases (ZFNs) due to its easily reprogrammable nature of the RNA base pairing to the target locus (15) . APEX2, in the presence of hydrogen peroxide, oxidizes the phenol moiety of biotin-phenol compounds to phenoxyl radicals that react with surface exposed tyrosine residues, labeling nearby proteins with biotin derivatives (14, 16, 17) . Affinity labeling in cells also circumvents the need for chemical crosslinking, a method used to stabilize biomolecular interactions that severely diminishes LC-MS/MS sensitivity. APEX2 was used instead of other promiscuous biotin ligases due its smaller labeling radius and shorter labeling times (18) (19) (20) .
The dCas9-APEX2 (Caspex) gene was cloned in frame with the self-cleaving T2A peptide and green fluorescent protein (Gfp) under the control of a tetracycline response element into a puromycin-selectable piggybac plasmid (21) (Figure 1C) .
HEK293T cells were transfected with the Caspex plasmid and after 14 days of puromycin selection, single colonies were expanded and characterized for doxycycline (dox) inducible expression of GFP. This clonal, stable line is subsequently referred to as 293T-Caspex. To test whether the CASPEX protein would correctly localize to a genomic site of interest, we expressed a single guide RNA (sgRNA) targeting 92 base pairs (bp) 3' of the transcription start site (TSS) of the TERT gene (sgRNA position is referred to as T092). We chose to focus on the TERT promoter (hTERT) as TERT expression is a hallmark of cancer and recurrent promoter mutations in hTERT have been shown to re-activate TERT expression (22) . Biotinylation in T092 sgRNA expressing 293T-CasPEX cells was accomplished by incubating cells with dox for 18 hours, followed by incubation with biotinphenol for 30 minutes, and finally with hydrogen peroxide for 60 seconds. We then performed ChIP against both the FLAG epitope of CASPEX, and biotin, followed by quantitative PCR (qPCR) of probes tiling hTERT ( Figure   1D ). ChIP-qPCR showed proper localization of CASPEX with the peak of the anti-FLAG signal overlapping with the destination of the sgRNA. The anti-biotin ChIP-qPCR signal showed a similar trend of enrichment, indicating that CASPEX biotinylates proteins in cells within approximately 400 base pairs on either side of its target locus.
No enrichment was observed at T092 for the no sgRNA control, which is not spatially constrained to the targeted locus ( Figure 1D) .
We then created four additional sgRNA constructs tiling hTERT: 430T, 107T, T266 and T959, where the number indicates the targeted position relative to TERT's TSS denoted by "T" (Figure 2A) . To test whether these sgRNAs were targeted properly, we created 293T-Caspex cells stably expressing the individual sgRNAs. After performing the labeling reaction, these lines were analyzed by ChIP-qPCR against FLAG and biotin. All constructs correctly targeted and labeled the region of interest, showing the peak of enrichment at the sgRNA site (Supplemental
Figure 1). While biotinylation was dependent on CASPEX expression, no difference in biotin patterns between
hTERT sgRNA lines could be seen by Western blot (Supplemental Figure 2) . These data demonstrate that CASPEX targeting can be reprogrammed by substitution of the sgRNAs and that proximal protein biotinylation is CASPEX mediated.
To test whether CASPEX could identify proteins associated with hTERT, we enriched biotinylated proteins with streptavidin-coated beads from hTERT -targeted 293T-Caspex lines, followed by analysis with quantitative LC-MS/MS. Biotinylation was initiated in the five individual hTERT targeting 293T-Caspex lines 18 hours after addition of doxycycline, along with the no guide control 293T-Caspex line. Whole cell lysates from each individual line were then incubated with streptavidin-coated magnetic beads, stringently washed, and subjected to on-bead trypsin digestion. Digests of the enriched proteins were labeled with isobaric tandem mass tags (TMT) (23) for relative quantitation, mixed for multiplexing, and subsequently analyzed by LC-MS/MS (Figure 1B) . We used a ratiometric approach of each individual sgRNA 293T-Caspex line compared to the no guide control line (24) , which is not spatially constrained to a locus in the genome by a sgRNA. From this analysis, we detected 3, 199 proteins, each with at least two quantifiable peptides. Biotinylation in four of the hTERT Caspex lines that Supplemental Table 1 ). These results indicate GLoPro is able enrich proteins from the native, cellular context, and suggests this method is capable of distinguishing proteins at a particular genomic locus.
In addition to detecting proteins known to associate with hTERT, we also identified several novel candidate proteins associated with this promoter region. To corroborate whether a subset the proteins identified by GLoPro associate with hTERT, we performed ChIP-qPCR for several candidates. Since many of these proteins do not have ChIP grade antibodies we turned to V5-tagged ORF expression in unmodified HEK293T cells (34) . Twentythree individual V5-tagged ORFs were chosen by availability, having ≥ 99% amino acid homology, and having an in-frame V5 tag. We selected 16 V5-tagged ORFs that spanned a range of significant enrichment values ( Figure 2D) . We also chose four V5-tagged ORFs for proteins not identified as significantly enriched at hTERT, and three proteins that were not detected as negative controls. To moderate overexpression, each ORF was individually expressed in HEK293T cells at one-fourth of the recommended DNA concentration. After 48 hours, the cells were subjected to anti-V5 ChIP-qPCR with probes tiling the regions targeted by the sgRNAs. Comparing ChIP-qPCR signals from each individual ORF to their respective GLoPro enrichment values (proteins not detected were assigned a GLoPro enrichment value of 0) we found that all proteins enriched in the GLoPro analysis were, as a group, statistically enriched by ChIP-qPCR (Mann-Whitney test, p = 0.0008) (Figure 2E ).
Most candidates deemed statistically enriched according to the GLoPro analysis were separated in the ChIP enrichment space from those not enriched or not detected. Two proteins previously described to bind hTERT, CTBP1 and MAZ (27, 28, 33) , were found in a regime of high ChIP enrichment and low GLoPro enrichment, suggesting ChIP-qPCR provides orthogonal information to GLoPro for protein occupancy at a genomic locus.
These data show that GLoPro can identify known, but also novel proteins that can be corroborated by ChIP-qPCR, that associate with hTERT.
To explore the generalizability of GLoPro at another site in the genome, we created 293T-Caspex cells that express individual sgRNAs that tile the c-MYC promoter (Figure 3A) . Here, we present a method for the unbiased discovery of proteins associated with particular genomic loci in live cells without genetically engineering the site of interest. We applied GLoPro to identify proteins associated with the hTERT and c-MYC promoters. Both well-established and previously unreported interactors of the respective promoter regions identified by GLoPro were validated using ChIP-qPCR, demonstrating that this method enables the discovery of proteins and pathways that potentially regulate a gene of interest without the need for prior knowledge of potential occupants.
GLoPro relies on the localization of the affinity labeling enzyme APEX2 directed by the catalytically dead CRISPR/Cas9 system to biotinylate proteins within a small labeling radius at a specific site in the genome in living cells. Other than the expression of Caspex and its associated sgRNA, no genome engineering or cell disruption is required to capture a snapshot of proteins associated with the genomic locus of interest. This advantage, in combination with the generalizability of dCAS9 and APEX2, suggests that GLoPro can be used in a wide variety of cell types and at any dCAS9-targetable genomic element. Beyond circumventing the need for antibodies for discovery, LC-MS/MS analysis using isobaric peptide labeling allows for sample multiplexing, enabling multiple sgRNA lines and/or replicates to be measured in a single experiment with little or no missing data for relative quantitation of enrichment. GLoPro-derived candidate proteins can be further validated for association with the genomic region of interest by ChIP, the current gold standard for interrogation of protein-DNA interactions. While GLoPro in this initial work only identifies association with a locus and not functional relevance, we expect that analyzing promoters or enhancer elements during relevant perturbations may provide novel functional insights into transcriptional regulation. In addition, we envision CASPEX can be used for enrichment of genomic locus entities such as locus-associated RNAs (i.e. nascent or non-coding RNAs) or DNA elements not targeted directly by CASPEX, but close in three-dimensional space within the nucleus (i.e. enhancers or promoters associated with an enhancer). Further work will be needed to assess the extended capabilities of CASPEX.
While we have demonstrated that GLoPro will be a powerful tool to study chromatin structure and transcriptional regulation, there are several drawbacks that should be noted, mainly concerning receptive cell systems and analyte sensitivity. We designed GLoPro to have an inducible expression system to prevent constant CASPEX association with the locus of interest, potentially disrupting gene expression. Thus, the inducible expression and selection cassette is currently too large for viral transduction (Figure 1C) . Ongoing work in our laboratory has found that co-transfecting the piggybac transposase aids the generation of stable Caspex lines in cell culture systems with poor transfection efficiency (data not shown). Thus, in its current form, Caspex can only be used in electroporation or transfectable cells. The second major challenge is sensitivity. Avoidance of chemical crosslinking, the high affinity of streptavidin for biotin, and sample multiplexing were boons for the development of GLoPro, but due to the inherent sensitivity limits of current mass spectrometers and the unavoidable sample loss at each sample handling step, a large amount of input material is needed. These input requirements are readily attainable with many cell culture systems but may prove more challenging with recalcitrant or limited passaging cells.
In summary, we describe genomic locus proteomics, a novel approach to identify proteins associated with a predefined site in the genome. This method provides an orthogonal and highly complementary approach to ChIP for the unbiased discovery of proteins that may regulate gene expression and chromatin structure. 
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Methods
Plasmid construction
The Caspex construct (dox inducible dCas9-APEX2-T2-GFP) was created by subcloning 3xFLAG-dCas9 and T2A-Gfp from pLV-hUBC-dCas9-VP64-T2A-GFP (Addgene 53192), and V5-APEX2-NLS from mito-V5-APEX2 (Addgene 42607) into an all in one piggybac, TREG/Tet-3G plasmid (Church lab) via ligation independent cloning (InFusion, Clontech). Guide sequences were selected and cloned as previously described (Doench et al). All V5 ORF constructs were purchased through the Broad Genetics Perturbation Platform and were expressed from the pLX-TRC_317 backbone. V5 ORFs were only selected for validation if the construct was available, had protein homology >98%, and an in frame V5 tag.
Cell Line construction and culture
HEK293T cells were grown in DMEM supplemented with 10% fetal bovine serum, glutamine and non-essential amino acids (Gibco). All constructs were transfected with Lipofectamine 2000. After Caspex transfection, puroMYCin was added to a final concentration of 4 ug/ml and selected for two weeks. Single colonies were picked, expanded and tested for doxycycline inducibility of the Caspex construct monitored by GFP detection.
The HEK293T cell line with the best inducibility (now referred to as 293-Caspex cells) was expanded and used for all subsequent experiments. For stable sgRNA expression, single sgRNA constructs were transfected into 293-Caspex cells and were selected for stable incorporation by hygroMYCin treatment at 200 ug/ml for two weeks. Caspex binding was tested using ChIP followed by digital droplet PCR (ddPCR) or qPCR.
APEX-mediated labeling
Prior to labeling, doxycycline dissolved in 70% ethanol was added to cell culture media to a final concentration of either 500 ng/mL for 18-24 hours (hTERT) or 12 hours at 1 ug/mL (c-MYC). Biotin tyramide phenol (Iris Biotech) in DMSO was added directly to cell culture media, which was swirled until the precipitate dissolved, to a final concentration of 500 uM. After 30 minutes at 37°C hydrogen peroxide was added to media to a final concentration of 1 mM to induce biotinylation. After 60 seconds the media was decanted and the cells were washed with ice cold PBS containing 100 mM sodium azide, 100 mM sodium ascorbate and 50 mM TROLOX (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) three times. Cells were lifted and transferred to 15 ml Falcon tubes with ice cold PBS, spun at 500g for 3 minutes, flash frozen in liquid nitrogen and stored at -80 o C.
Chromatin immunoprecipitation followed by quantitative PCR
Cells were trypsinized to single cell suspension and fresh formaldehyde was added to a final concentration of 1% and incubated at 37°C for 10 minutes, being inverted several times every two minutes or so. Formaldehyde was quenched with 5% glycine and the samples were aliquoted into 3e6 cell aliquots, spun down and flash frozen in 0.5 mL Axygen tubes. Chromatin was sheared using a QSonica Q800R2 Sonicator at and amplitude of 50 for 30 seconds on/30 off, for 7.5 minutes, until 60% of fragments were between 150 and 700bp. Lysis buffer was 
Western blot analysis
sgRNA-293-Caspex cells were labeled as described above. 40 ug of whole cell lysate was separated by SDS-PAGE, transferred to nitrocellulose and blotted against FLAG (Sigma) or biotin (Li-Cor IRdye 800 CW Streptavidin and IRdye 680RD anti-Mouse IgG).
Enrichment of biotinylated proteins for proteomic analysis
Eight 15 cm2 plates of each sgRNA-293-Caspex line, or no guide as a negative control, were used for proteomic experiments. Labeled whole cell pellets were lysed with RIPA (50 mM TRIS pH 8.0, 150 mM NaCl, 1% NP-40 and 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate) with protease inhibitors (Roche) and probe sonicated to shear genomic DNA. Whole cell lysates were clarified by centrifugation at 14,000g for 30 minutes at 4°C and protein concentration was determined by Bradford. 500 uL SA magnetic bead slurry (Thermo) was used for each sgRNA line (between 60-90 mgs of protein/state). Lysates of equal protein concentrations were incubated with SA for 120 minutes at room temperature, washed twice with cold lysis buffer, once with cold 1M KCl, once with cold 100 mM Na3CO2, and twice with cold 2 M urea in 50 mM ammonium bicarbonate (ABC).
Beads were resuspended in 50 mM ABC and 300 ng trypsin and digested at 37oC overnight.
Isobaric labeling and liquid chromatography tandem mass spectrometry
On-bead digests were desalted via Stage tip (37) and labeled with TMT (Thermo) using an on-column protocol.
For on-column TMT labeling, Stage tips were packed with one punch C18 mesh (Empore), washed with 50 uL methanol, 50 uL 50% acetonitrile (ACN)/0.1% formic acid (FA), and equilibrated with 75 uL 0.1% FA twice. The digest was loaded by spinning at 3,500g until the entire digest passed through. The bound peptides were washed twice with 75 uL 0.1% FA. One uL of TMT reagent in 100% ACN was added to100 uL freshly made HEPES, pH 8, and passed over the C18 resin at 2,000g for 2 minutes. The HEPES and residual TMT was washed away with 75 uL 0.1% FA twice and peptides were eluted with 50 uL 50% ACN/0.1% FA followed by a second elution with 50% ACN/20 mM ammonium hydroxide, pH 10. Peptide concentrations were estimated using an absorbance reading at 280 nm and mixed at equal ratios. Mixed TMT labeled peptides were step fractionated by basic reverse phase on a sulfonated divinylbenzene (SDB-RPS, Empore) packed Stage tip into 6 fractions (5, 10, 15, 20, 30 and 55% ACN in 20 mM ammonium hydroxide, pH 10). Each fraction was dried via vacuum centrifugation and resuspended in 0.1% formic acid for subsequent LC-MS/MS analysis.
Chromatography was performed using a Proxeon UHPLC at a flow rate of 200 nl/min. Peptides were separated at 50°C using a 75 micron i.d. PicoFit (New Objective) column packed with 1.9 um AQ-C18 material (Dr. Maisch) to 20 cm in length over a 94 min gradient. Mass spectrometry was performed on a Thermo Scientific Q Exactive Plus (hTERT data) or a Lumos (c-MYC data) mass spectrometer. After a precursor scan from 300 to 2,000 m/z at 70,000 resolution the top 12 most intense multiply charged precursors were selected for HCD at a resolution of 35,000. Data were searched with Spectrum Mill (Agilent) using the Uniprot Human database, in which the CASPEX protein was amended. A fixed modification of carbamidomethylation of cysteine and variable modifications of N-terminal protein acetylation, oxidation of methionine, and TMT-10plex labels were searched.
The enzyme specificity was set to trypsin and a maximum of three missed cleavages was used for searching.
The maximum precursor-ion charge state was set to 6. The precursor mass tolerance and MS/MS tolerance were set to 20 ppm. The peptide and protein false discovery rates were set to 0.01.
Data analysis
All non-human proteins and human proteins identified with only one peptide were excluded from downstream analyses. Human keratins were included in all analyses but were removed from the figures. The moderated Ttest was used to determine proteins statistically enriched in the sgRNA-293-Caspex lines compared to the no sgRNA control. After correcting for multiple comparisons (Benjamini-Hochberg procedure), any proteins with an adjusted p-value of less than 0.05 were considered statistically enriched.
Pathway analysis was performed using the Quack algorithm incorporated into Genets (http://apps.broadinstitute.org/genets) to test for enrichment of canonical pathways in the Molecular Signature Database (MSgiDB). Proteins identified as significantly enriched (adj. p-val. < 0.05) by GLoPro were input into Genets and were queried against MSigDB. Pathways enriched (FDR < 0.05) were investigated manually for specific proteins for follow-up. 
